MARK2 and Alzheimer disease: MAPKs are serine-threonine kinases that mediate intracellular signaling and play an important role in regulating aging [54–56], with deviation from strict control of the MAPK signaling pathways implicated in many human neurodegenerative diseases, including AD and PD [57, 58].